CRMD Q2 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$50,748

Operating Income

-$12M

Net Income

-$11M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$57M

Total Liabilities

$8M

Stockholders' Equity

$49M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$21,253	-100.0%
Gross Profit	-$50,748	$20,921	-342.6%
Operating Income	-$12M	-$8M	-43.3%
Net Income	-$11M	-$8M	-48.2%